BME vs BRK-A
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full bankruptcy risk assessment. Despite a high dividend yield of 7.43%, the unsustainable 162.83% payout ratio raises concerns about dividend continuity. Profitability metrics show mixed signals with a 100% gross margin but zero profit margin and negative ROE of -4.63%, suggesting underlying operational inefficiencies. The technical trend score of 10/100 indicates strong bearish momentum, further weakening the investment case.
BRK-A shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
BME vs BRK-A: Head-to-Head Comparison
This page compares BlackRock Health Sciences Trust (BME) and Berkshire Hathaway Inc. (BRK-A) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.